TIRZEPATIDE/L-CARNITINE (MDV) 25/50MG/ML **3ML**, VMC, Victory Medical Center Pharmacy, Austin, Texa
Lack of Processing Controls — TIRZEPATIDE/L-CARNITINE (MDV) 25/50MG/ML **3ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
Severity not yet assessed
We have not scored this recall against our rubric yet, so we are not showing a severity rating or our usual guidance. The agency’s own notice below is the authoritative source — read it first.
Plain-English summary
Lack of Processing Controls
The recalled product
- Product
- TIRZEPATIDE/L-CARNITINE (MDV) 25/50MG/ML **3ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas
- Manufacturer
- Victory Medical Center Pharmacy
- Category
- Drug — Drugs
- Affected units
- 343
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lot
- expiry: Lot 2053172
- exp 10/24/2026
- Lot 2028876
- exp 10/27/2026
- Lot 2060129
- exp 11/3/2026
Distribution
Related recalls
Same manufacturer · Victory Medical Center Pharmacy
See all →- CriticalVictory Medical Center Pharmacy Recalls Glutathione Vials Due to Contamination
FDA (Drugs) · 2026-08-19
Other drug recalls
- ModerateABC Compounding Recalls PRO CHEM BAN AID Antiseptic Hand Soap
FDA (Drugs) · 2026-11-04
- ModerateABC Compounding Recalls Chemseptic Due to Manufacturing Deviations
FDA (Drugs) · 2026-11-04
- SevereAtorvastatin Calcium Tablets Recalled for Presence of Foreign Tablets or Capsules
FDA (Drugs) · 2026-11-04
- ModerateABC Compounding Recalls Freshhands Foamy Antibacterial Hand Soap
FDA (Drugs) · 2026-11-04
- LowMeitheal Pharmaceuticals Recalls Vecuronium Bromide Injection for Labeling Defect
FDA (Drugs) · 2026-11-04